OncoLens brings multidisciplinary cancer care into focus
About OncoLens
What We Do
We envision a world where every cancer patient has access to the best possible minds, therapies and innovations in care – in time to make a difference.
With OncoLens, we bring together leading edge technology with the smartest minds in cancer care to deliver an innovative platform to support a new generation of cancer centers.
Better Patient Care
Clinician Empowerment
Enriched Care Planning
Clinical Decision Support
Our History
It’s hard to find someone in today’s world that has not been impacted by cancer, either themselves or a loved one. That was the case for OncoLens Co-Founder and CEO, Anju Mathew. Her personal family struggles with cancer brought to life the importance of a multidisciplinary approach to cancer care. As an experienced entrepreneur and technologist, she knew there had to be a better way.
Soon Anju began to collaborate with Dr. Lijo Simpson, a board-certified Hematologist/Oncologist and active participant in various cancer committees. Dr. Simpson understood first-hand the administrative burdens that a multidisciplinary approach to cancer care places on facilities. But he also understood the many advantages this approach brought to care teams and patients.
Together, they knew they could solve the challenges that were placing artificial limitations on the patients who could benefit from multidisciplinary cancer care. Together, they formed OncoLens.
Recent Timeline of OncoLens Milestones
2023
-
Onboarded our 200th cancer center
-
Launched integration with Caris Labs to improve access and understanding of targeted therapies
-
Launched Patient Id solution for clinical trials and biomarker testing
2022
-
Awarded SOC 2 Certification
-
Global Expansion to the Middle East
-
Molecular Module Released: Targeted Biomarker Treatment Planning
2021
-
Collaborate Module Released: Secure Expert Opinions and Patient Referrals Beyond Health System Walls
-
Onboarded our 100th Cancer Center
2020
-
OncoLens EMR Integration Solution Goes Live
-
Rapid COVID Response: Released Virtual Tumor Board Capabilities
2019
-
Celebrated three-year anniversary of first customer, successfully completes CoC accreditation survey
-
Launched Survivorship care plan module
2018
-
OncoLens selected as one among 30 showcase companies selected from hundreds of innovative young businesses from across the Southeast at Venture Atlanta
-
Dr. Simpson, OncoLens Chief Medical Officer, presents at ACCC Business Summit, in Washington D.C., establishing thought leadership in modern technology and clinical outcomes
2017
-
Received Exceptional Research award at AONN, for work done in streamlining cancer conferences at Emory Decatur Hospital
-
Emory Decatur Nurse Navigators present results of utilization of OncoLens to streamline LDCT screening process at Oncology Nurse Navigator Conference, Austin TX
-
Market launch of Tumor Board Management module after successful deployment at Emory Decatur Hospital
Who We Serve
Physicians
Lower cognitive load, ease coordination, access a single, comprehensive patient view, enable precision medicine, leverage clinical trial matching, and ease outreach for second opinions and insights
Nurse Navigators
Improve care coordination and patient outcomes, lower administrative demands and free-up time for patient care; manage patient tracking and survivorship care plans
Cancer Center Administrators
Improve the quality of care, ensure accreditation, and streamline referrals across the network
Cancer Registrars
Reduce time spent on data collection, case finding and conference planning, assign more cases per conference, and ease reporting to facilitate accreditation